Articles by Emily Menendez
A study compared the gross and OOP payments for 6 different first-line mCRPC drugs during the 6 months post-treatment start.
Researchers developed a randomized phase II clinical trial for patients with NMIBC before transurethral resection of tumors.
Researchers performed a cost-effectiveness analysis of sunitinib and 6 immunotherapy-TKI/immunotherapy drug combinations.
A recent update on the phase 3 MIRAGE trial determined if MRI or CT-guided stereotactic body radiotherapy is most effective.
Researchers examined the impact of care fragmentation on patients receiving neoadjuvant chemotherapy and radical cystectomy.
Prostate cancer drug abiraterone acetate has recently been developed in an oral suspension form as an alternative to tablets.
GU Oncology Now spoke with Shyam Natarajan to discuss Avenda's iQuest and how AI can be used in the field of cancer care.
Our industry insights compile monthly news and updates across the GU oncology sphere.
A study analyzed 228 patients with penile cancer who underwent pelvic lymph node treatment with curative intent.
While PSMA-RLT is typically used during later disease stages, patients in earlier disease stages may benefit as well.
670 Madison Ave.
Manalapan, NJ 07726
© 2023 Mashup Media, LLC. All rights reserved.